National Health Investors (NHI) Tops Q3 EPS by 2c, Revenues Beat; Offers FY19 EPS Guidance
National Health Investors (NYSE: NHI) reported Q3 EPS of $0.97, $0.02 better than the analyst estimate of $0.95. Revenue for ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)